Did celc ever did reverse stock split?

``` The deep research logic is organized as follows: Okay, let's tackle this question: "Did CELC ever do a reverse stock split?" First, I need to check the provided references to see if there's any mention of Celcuity (CELC) performing a reverse stock split. Looking through the references, I see several entries related to stock splits. Number 2 mentions Celcuity's stock split history from 2017, but it says there are no results found. Number 4 also states that there's no stock split history for CELC. Then, Number 17 talks about Celcuity's Phase 3 trial results, but nothing about stock splits. Wait, but there's a reference to Celularity (CELU) in Number 3 and 13. Celularity is a different company, right? They did a 1-for-10 reverse stock split in 2024. However, the user is asking about CELC, which is Celcuity. The references for CELC (Numbers 1, 2, 4, 8, 12, 16, 20, 25) all indicate no reverse stock split history. So, putting this together, Celcuity (CELC) hasn't done a reverse stock split. Celularity (CELU) did, but they're separate companies. The user might be confusing the two. I should clarify that in the answer, making sure to distinguish between CELC and CELU. Also, check if there are any other mentions in the references that might suggest a split for CELC, but it seems all relevant ones say there's no history. I need to structure the answer clearly, stating that CELC hasn't done a reverse split, mention the confusion with Celularity, and cite the relevant references. Also, include the visualization as per the requirements. Make sure the conclusion is upfront and the analysis follows with the necessary details and citations. ``` ### Conclusion 📉 **No, Celcuity Inc. (CELC) has never conducted a reverse stock split.** However, there is confusion in the market due to Celularity Inc. (CELU), a separate biotechnology company, which executed a 1-for-10 reverse stock split in February 2024 . Below is a detailed analysis to clarify the distinction between the two companies and confirm CELC’s stock split history. --- ### 📊 **Analysis of CELC’s Stock Split History** #### 1. **Celcuity Inc. (CELC): No Reverse Stock Split History** - **Stock Split Data:** Multiple sources confirm that Celcuity Inc. (CELC) has no recorded reverse stock split history since 2017 . - **Market Context:** CELC focuses on developing targeted therapies for oncology, with recent clinical milestones in breast cancer treatments . The company’s stock price surged 167% in July 2025 following positive Phase 3 trial results . | Company | Stock Symbol | Reverse Stock Split History | Key Activities (2025) | |---------|--------------|------------------------------|--------------------------| | Celcuity Inc. | CELC | None | Phase 3 trial success, $225M capital raise | #### 2. **Celularity Inc. (CELU): Confusion with CELC** - **Reverse Stock Split:** Celularity Inc. (CELU) executed a 1-for-10 reverse stock split in February 2024 to comply with Nasdaq’s minimum bid price requirement . - **Market Context:** CELU focuses on allogeneic cell therapies and biomaterials, with a post-split share count reduced from ~217M to ~21.8M . | Company | Stock Symbol | Reverse Stock Split History | Key Activities (2024) | |---------|--------------|------------------------------|--------------------------| | Celularity Inc. | CELU | 1-for-10 reverse split | FDA compliance, cell therapy development | --- ### 📊 **Why This Matters for Investors** - **CELC Investors:** Focus on CELC’s clinical pipeline and financial flexibility ($225M capital raise in 2025) . - **CELU Investors:** Monitor CELU’s post-split trading dynamics and regulatory milestones . - **Key Takeaway:** CELC and CELU are distinct companies with separate stock split histories and business models. For high-growth tech investors (e.g., Figma, Adobe), this distinction highlights the importance of verifying company-specific data before making investment decisions. Stay vigilant on stock split announcements and clinical trial results! 🚨